---
title: Osteoporosis
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[Huppert's Notes]]
 Osteoporosis #ðŸš§ æ–½å·¥ä¸­

### Osteoporosis

â€¢Â Â Â Bone biology:

-Â Â Â Osteoblasts promote bone formation and osteoclasts promote bone absorption/breakdown. Bone remodeling is a balance of osteoblast and osteoclast activity

-Â Â Â Inflammatory diseases cause the upregulation of RANK-ligand, which activates osteoclasts and drives bone loss

â€¢Â Â Â Risk factors:

-Â Â Â Older age, gender (F>M, accelerated bone loss after menopause due to decreased estrogen), past fractures, family history of osteoporosis, low BMI, smoking, alcohol use, prolonged steroid use

-Â Â Â Medical conditions: Endocrine disorders (e.g., hyperthyroidism, Cushingâ€™s, hypogonadism), GI disorders (e.g., IBD, celiac disease, post gastric bypass), rheumatologic disorders (e.g., rheumatoid arthritis)

â€¢Â Â Â Screening:

-Â Â Â Screen all women >65 yr; consider screening younger women if risk factors for osteoporosis (fragility fracture, low BMI, high risk medication use)

-Â Â Â Per USPSTF screening guidelines, there is insufficient evidence to recommend universal screening in men but can consider screening if risk factors for osteoarthritis

â€¢Â Â Â Diagnosis:

-Â Â Â DEXA: Measures tissue absorption of photons to calculate the bone mineral density (BMD)

-Â Â Â WHO diagnostic criteria for osteoporosis based on DEXA score:

**â€¢**Â Â Â T score >-1.0: Normal bone density

**â€¢**Â Â Â T score -1.0 to -2.5: Osteopenia

**â€¢**Â Â Â T score <-2.5: Osteoporosis

-Â Â Â Fracture Risk Assessment Tool (FRAX): Estimates 10-yr probability of fracture if no bone-directed treatment is initiated; incorporates DEXA femoral neck bone mineral density and risk factors

â€¢Â Â Â Treatment:

-Â Â Â Treatment indicated if osteoporosis or osteopenia AND history of hip or vertebral fracture, 10-yr risk of hip fracture >3% or 10-yr risk of any osteoporosis fracture >20%

-Â Â Â Universal recommendations:

**â€¢**Â Â Â Lifestyle modifications: Exercise, smoking cessation, limiting alcohol intake

**â€¢**Â Â Â Calcium supplementation (typically 1200 mg daily)

**â€¢**Â Â Â Vitamin D supplementation (typically 800 IU daily)

-Â Â Â Bisphosphonates:

**â€¢**Â Â Â Most common first-line therapy for osteoporosis

**â€¢**Â Â Â Mechanism: Inhibits osteoclasts

**â€¢**Â Â Â Examples: Alendronate (Fosamax) 5 mg daily or 35 mg weekly orally; ibandronate (Boniva); risedronate (Actonel); zolendronic acid (Reclast, IV formulation)

**â€¢**Â Â Â Administration: Most oral bisphosphonates are taken once a week, 30 minutes before eating (need to take on an empty stomach). Consider stopping after 5 yr of treatment.

**â€¢**Â Â Â Check calcium and vitamin D before and during treatment and ensure replete

**â€¢**Â Â Â Side effects: Heartburn, esophageal irritation, osteonecrosis of the jaw (ensure preventative dental work done prior to starting treatment), atypical sub-trochanteric femur fracture (presents with thigh pain, may be bilateral)

**â€¢**Â Â Â Contraindication: Pregnancy, CKD

-Â Â Â Raloxifene (Evista):

**â€¢**Â Â Â Mechanism: Serum estrogen receptor modulator that inhibits bone resorption

**â€¢**Â Â Â Clinical use: Only useful in vertebral osteoporosis

**â€¢**Â Â Â Side effects: Hot flashes, DVT, leg cramps

**â€¢**Â Â Â Contraindications: Pregnancy, prior DVT/PE

-Â Â Â Calcitonin:

**â€¢**Â Â Â Mechanism: Inhibits osteoclasts

**â€¢**Â Â Â Administration: Given as a daily intranasal spray

**â€¢**Â Â Â Side effects: Risk of anaphylaxis

-Â Â Â Denosumab (Prolia):

**â€¢**Â Â Â Mechanism: Anti-RANK ligand, inhibits osteoclasts

**â€¢**Â Â Â Side effects: Hypocalcemia, osteonecrosis of the jaw, atypical sub-trochanteric femur fractures

**â€¢**Â Â Â Contraindications: Pregnancy

-Â Â Â Teriparatide (Forteo):

**â€¢**Â Â Â Mechanism: Increases bone remodeling, analog of PTH

**â€¢**Â Â Â Administration: Daily injection. Should not be administered for more than 2 yr in duration

**â€¢**Â Â Â Side effects: Nausea, leg cramps, dizziness

â€¢Â Â Â Monitoring: Repeat DEXA 2 yr after initiating treatment

